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Previously, we described a family of novel broad spectrum antimicrobial peptides, magainins, from the skin of Xenopus 
kzevis. In this report we show that at least two other Xenopus peptides, present in the skin and its secretions, PGLa and 
a peptide released from the xenopsin precursor, exhibit antimicrobial properties comparable to the magainins. The identi- 
fication of these newer members provides insight into the structural diversity of vertebrate antimicrobial peptides. 
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1. INTRODUCTION 
We have previously reported the isolation of two 
abundant antimicrobial peptides called ‘magain- 
ins’ from the skin of the South African clawed 
toad, Xenopus laevis [1,2]. Recently, a com- 
prehensive analysis of peptides present in the secre- 
tions of thegranular glands of the skin of Xenopus 
was published [3]. Major components of these 
secretions were shown to include the magainin pep- 
tides (called ‘PGS’ in [3]), the 21 residue peptide 
PGLa [3-61, and a 25 residue peptide which 
derives from the xenopsin precursor (XPF) [3,6,7]. 
PGLa and XPF have no known function but have 
been recognized as potentially membrane-active 
substances [3-61. Although these peptides share no 
significant sequence similarity to the magainins, 
their similar size, potential amphilicity, abun- 
dance, and glandular location suggested to us that 
they might share with the magainins a common an- 
timicrobial activity. In this report we show that 
both PGLa and XPF exhibit broad spectrum an- 
timicrobial activity comparable to the magainins. 
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The results demonstrate that the magainins repre- 
sent members of a surprisingly diverse population 
of antimicrobial peptides present within the am- 
phibian neurosecretory structure. 
2. MATERIALS AND METHODS 
Antibacterial and antiprotozoan activity were assayed as 
described [1,2]. Peptides were synthesized by the solid-phase 
procedure [8] as described [2,5] by Dr Jean River (Salk In- 
stitute, La Jolla, CA) and Michael Brasseur (Applied 
Biosystems, Foster City, CA). 
3. RESULTS 
PGLa, the xenopsin precursor fragment (XPF) 
and magainin 2 were synthesized as the carboxyl- 
terminal amides by the solid-phase method [8] as 
described [2,5] and purified to homogeneity by 
reverse-phase high-pressure liquid chromatogra- 
phy [2,5]. Sequences of these peptides are shown in 
table 1. 
The synthetic peptides were assayed for an- 
timicrobial activity by methods described in [ 1,2]. 
When applied to a lawn of E. cofi, XPF, PGLa 
and magainin 2 displayed comparable antibacterial 
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Table 1 
Sequences of the natural peptides 
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS [l-3] 
XPF GWASKIGQTLGKIAKVGLKELIQPK [3] 
PGLa GMASKAGAIAGKIAKVALKAL (NHs) [4] 
The synthetic peptides used in this report all bear carboxyl- 
terminal amides 
Fig.1 
activities (fig.1). An analogue of magainin 2, in 
which all Lys and Phe residues had been synthe- 
sized with D enantiomers (peptides Z), displayed 
markedly reduced activity, serving as control and 
demonstrating the specificity of the antimicrobial 
assay. 
When assayed against several species of bacteria 
and fungi in liquid medium, both XPF and PGLa 
exhibited antimicrobial potencies comparable to 
that observed for magainin 2 (table 2). However, 
the precise spectrum of antibiotic activity differed 
between the peptides. Thus, magainin 2 and XPF 
displayed higher specific activity against 
Pseudomonas than did PGLa, while PGLa was the 
most active against Staphylococcus aureus. At 
minimal inhibitory concentrations, all three pep- 
tides exhibited bactericidal activity against the 
organisms assayed in table 2, with greater than 
90% killing observed by the first hour of incuba- 
tion (not shown). 
Synthetic magainin peptides were previously 
shown to rapidly induce osmotic lysis of several 
protozoan species [2]. Consequently, both XPF 
and PGLa were assayed for similar antiprotozoan 
activity. As shown in table 3, XPF and PGLa ex- 
hibited potent activity against Paramecium 
caudatum, Acanthamoeba castellani and Tetra- 
hymena pyriformis. As seen with magainin pep- 
tides, both PGLa and XPF rapidly inhibited 
contractile vacuole function, resulting in pro- 
gressive swelling of the organism followed by even- 
tual rupture. It would appear that each of the three 
peptides acts on a common intracellular site in this 
complex microbial target. 
The amino acid sequences of magainin, PGLa 
and XPF permit them to be configured into an am- 
Table 2 
Spectrum of antimicrobial activity of Xenopus granular gland peptides 
Organism (ATCC) Minimal inhibitory concentration &g/ml) 
Magainin 2 PGLa XPF 2 
Escherichia co/i (25922) lo- 50 lo- 50 lo- 50 >lOOO 
Pseudomonas aeruginosa (27883) 50-100 200-500 50-100 >lOOO 
Staphylococcus aureus (25923) >500 50-100 100-200 >lOOO 
Streptococcus pyogenes (19615) lo- 50 lo- 50 lo- 50 >lOOO 
Saccharomyces cerevisiae (A3 180) 50-100 100-200 200-500 > 1000 
Candida albicans (14053) 200-500 100-200 200-500 > 1000 
lo5 organisms were inoculated from late-log phase cultures into 0.5 ml of TSB broth 
containing synthetic peptides at concentrations of 10, 50, 100, 200, 500 and 
lOOOpg/ml. Cultures were incubated at either 37°C (bacteria) or 30°C (fungi) for 
24 h. Concentration range of peptide at which no visible growth of inoculum occurred 
is listed. Peptide Z is [DLys4”0~“~‘4,PPhe5~‘2.‘6 ]-magainin 2 carboxy-terminal mide 
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Table 3 
Sensitivity of protozoa to synthetic Xenopus granular gland 
peptides 
Organism Minimal disruptive concentration 
&g/ml) 
Magainin 2 PGLa XPF Z 
Paramecium caudatum 10 5 10 2250 
Tetrahymena pyriformis 20 20 20 > 250 
Acanthamoeba castellani 2 2 2 30 
Protozoa (about 10’) were suspended into 200 ~1 of 1% 
trypticase soy broth in distilled water on a glass depression 
slide. Actively growing cultures of P. caudatum and T. 
pyriformis were obtained from Nasco (WI) and A. castellani 
from B. Bowers (NHLBI). Peptides were added to various 
concentrations and the organisms visually assessed by light 
microscopy within 15 min of exposure. The concentrations 
listed represent the minimal peptide concentration at which 
physical disruption of all protozoa occurred 
phiphilic a-helix [l-6]. Indeed, we have recently 
demonstrated by two dimensional nuclear 
magnetic resonance spectroscopy, that magainin 2 
adopts an a-helical structure in the presence of low 
concentrations of trifluoroethanol [12]. Although 
amphiphilic peptides can be membrane disruptive, 
the magainins have been shown previously to ex- 
hibit little hemolytic activity against human 
erythrocytes [11. As seen in table 4, both PGLa and 
XPF, exhibit very low hemolytic activity, quan- 
titatively identical to magainin 2. As a class, 
Table 4 
Hemolytic activity of Xenopus peptides 
Peptide &g/ml) Peptide (Vo hemolysis) 
Magainin 2 PGLa XPF Mellitin 
0 0 0 0 0 
50 4 4 1 100 
100 3 3 1 - 
200 3 4 2 - 
500 4 5 5 - 
1000 6 7 6 - 
Peptides, at the stated concentrations, were added to a 5% 
suspension of freshly drawn human erythrocytes, which had 
been washed twice in phosphate buffered saline. After 
incubation at 37°C for 30 min, the suspension was centrifuged 
at 10000 x g for 10 min and the A400 of the supernatant 
determined. 100% hemolysis was determined by addition of 
0.2% Triton X-100 to a standard reaction 
therefore, they are distinguished from lytic pep- 
tides, such as mellitin [9], and bombinin [lo], 
which are potent cytotoxic hemolytic substances. 
4. DISCUSSION 
In this report we have shown that in addition to 
the magainins, at least two other peptides found in 
the secretion of granular gland of Xenopus luevis 
exhibit broad-spectrum antimicrobial activity. Our 
failure to detect these species during our initial 
analysis of antimicrobial activity in Xenopus skin 
extracts probably reflects the relatively greater 
abundance of the magainin peptides [3] and selec- 
tive losses of PGLa and XPF during extraction and 
purification. Although we have examined only two 
granular gland peptides for antimicrobial activity, 
other candidates with potential comparable ac- 
tivities may well be present in the skin. It appears 
that antimicrobial peptides may represent a larger 
family than initially expected in this amphibian. 
The basis for this diversity remains unclear. If, 
however, these peptides serve an antimicrobial 
function in vivo, together they may provide a more 
comprehensive spectrum of action than afforded 
by an individual peptide. 
Despite the common antimicrobial property ex- 
hibited by these peptides it is striking that as a 
group they do not share a common amino acid se- 
quence of any significant length (table 1). The ex- 
tensive homology observed between XPF and 
PGLa has been noted previously and extends over 
much of the length of the corresponding precur- 
sors [7]. However, as a group, these peptides clear- 
ly share certain features that must play a role in 
their antimicrobial activity: they are at least 21 
residues in length, sufficient to span a lipid bilayer 
in an a-helical configuration [lo]; they can be con- 
figured into a-helical structures in which 
hydrophilic side chains align along one face, while 
hydrophobic side chains align along the other, a 
property of membrane-active peptides [lo]; they 
are composed of predominantly basic and 
hydrophobic residues. Recent conductance studies 
utilizing magainin 2 have demonstrated the capaci- 
ty of this peptide to form voltage-dependent anion- 
specific channels in synthetic bilayers (Cruciani et 
al., in preparation). To explain this property, 
which may underlie the antimicrobial activity of 
magainin, we have speculated that individual 
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monomers, configured as a-helical structures, 
organize to form a transmembrane channel 
(Feldmann, R. et al., unpublished). Whether 
PGLa and XPF, which can be modelled into 
similar channel structures, exhibit similar 
ionophoric properties is currently under study. 
The localization of an antimicrobial peptide, 
XPF, as part of the same precursor as xenopsin, an 
8 residue vasoactive peptide [l l] is intriguing. 
Xenopsin has been identified in many tissues of 
Xenopus in addition to skin, including gut and 
brain [ll]. Its widespread distribution and 
biological activity has led to the suggestion that 
xenopsin may play a role in wound repair and in- 
flammation, as a regulator of local blood flow and 
vascular permeability [111. The demonstration that 
the xenopsin precursor yields an antimicrobial pep- 
tide in addition to xenopsin, further supports a 
role for this family of peptides in wound repair and 
defense, 
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